Q3 organic sales growth beat boosts Novonesis shares

Novozymes A/S

06/11/2025 08:36

** Shares in Danish biosolutions company Novonesis NSISb.CO rise 5.4% after it reported Q3 organic sales growth above market estimates

** Its Q3 sales grew 6% on an organic basis vs consensus estimate of 4.5%, and were EUR 1,064.9 million ($1.24 billion)

   ** Novonesis also said it expects mid-single-digit organic sales growth for the fourth quarter

** Its full-year organic sales growth outlook is narrowed to 7-8% (previously 6-8%), and adjusted EBITDA margin guidance for the lower end of 37-38%

        ** J.P. Morgan says 3Q25 organic sales growth is "well above" JPMe/company consensus, with some benefit from order timing moving some sales from 4Q into 3Q

** The broker adds that Q4 guidance is likely to be seen as reassuring given the softer growth indications seen elsewhere in the sector

** "This is possibly the best print of the season so far and the stock is likely to outperform today" - JPM

** If gains hold, Novonesis shares are on track for their best day since February 26

($1 = 0.8575 euros)

 (Reporting by Elviira Luoma)

 ((Elviira.luoma@thomsonreuters.com))